Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) fell 6.4% on Wednesday . The company traded as low as $125.50 and last traded at $126.74. Approximately 72,082 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 680,530 shares. The stock had previously closed at $135.39.
Wall Street Analyst Weigh In
Several research analysts have commented on ACLS shares. Bank of America lifted their target price on Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a report on Tuesday, June 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Friday, August 7th. Finally, Craig Hallum lowered Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a research note on Friday, August 7th. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $132.20.
Read Our Latest Analysis on Axcelis Technologies
Axcelis Technologies Stock Performance
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last announced its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.89 by $0.17. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%.The company had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. During the same quarter in the prior year, the company earned $1.13 EPS. The firm’s revenue for the quarter was up 10.6% compared to the same quarter last year. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. Analysts forecast that Axcelis Technologies, Inc. will post 3.21 earnings per share for the current fiscal year.
Insider Activity at Axcelis Technologies
In other Axcelis Technologies news, VP Todd Sutton sold 2,000 shares of Axcelis Technologies stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $159.99, for a total value of $319,980.00. Following the completion of the sale, the vice president directly owned 6,360 shares of the company’s stock, valued at approximately $1,017,536.40. The trade was a 23.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Gerald M. Blumenstock sold 1,161 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $152.70, for a total transaction of $177,284.70. Following the transaction, the executive vice president owned 20,493 shares in the company, valued at $3,129,281.10. This represents a 5.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 5,673 shares of company stock valued at $890,967 in the last ninety days. Insiders own 0.49% of the company’s stock.
Hedge Funds Weigh In On Axcelis Technologies
Large investors have recently modified their holdings of the company. Victory Capital Management Inc. lifted its stake in shares of Axcelis Technologies by 85.9% in the fourth quarter. Victory Capital Management Inc. now owns 1,807,404 shares of the semiconductor company’s stock valued at $145,207,000 after buying an additional 835,242 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Axcelis Technologies by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 844,097 shares of the semiconductor company’s stock valued at $78,565,000 after acquiring an additional 3,057 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after acquiring an additional 44,275 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in Axcelis Technologies by 3,402.5% during the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock valued at $45,772,000 after purchasing an additional 477,705 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in Axcelis Technologies by 23.8% during the 4th quarter. Invesco Ltd. now owns 478,897 shares of the semiconductor company’s stock worth $38,475,000 after purchasing an additional 92,162 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors.
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Featured Articles
- Five stocks we like better than Axcelis Technologies
- Why Lowe’s Could Be a Bargain Before Housing Recovers
- Okta’s AI Tailwind Could Put This Forgotten Software Stock Back in Play
- Datavault AI Locks Down CyberCatch in $94M Security Rollup
- Quantum Stocks Are Starting to Choose Sides: Should Investors Do the Same?
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
